DJO

Medical Footwear Global Market Report 2022 Featuring Major Players - Aetrex Worldwide, Orthofeet, Duna, Darco International, Dr. Zen, Gravity Defyer, Dr. Foot Inc., DJO, and Horng Shin Footwear - ResearchAndMarkets.com

Retrieved on: 
Lunedì, Luglio 18, 2022
Medical Devices, Health, DJO, Application, Patient, Person, Medicine, Arthritis, Achilles tendinitis, MI, Organization, Diabetes, UA, Pain, Growth, Prevalence, Bunion, Shoe, Armour, Shoe Show, Foot, Diabetic foot, Arthralgia, Shoemaking, Medical device

Major players in the medical footwear market are Aetrex Worldwide Inc., Orthofeet, Duna, Darco International Inc., Dr. Zen Inc., Gravity Defyer Corp., Dr.

Key Points: 
  • Major players in the medical footwear market are Aetrex Worldwide Inc., Orthofeet, Duna, Darco International Inc., Dr. Zen Inc., Gravity Defyer Corp., Dr.
  • A few medical conditions that can benefit by this medical footwear include people with diabetic foot, corns, calcaneal spurs, heel cracks, and heel pain.
  • The main product types in medical footwear are medical shoes and boots, medical sandals, and others such as slippers, flip-flops, and insoles.
  • By application, the medical footwear market is segmented into diabetic shoes, arthritis shoes, bunions and hallux valgus shoes, and flat feet shoes.

Insights on the Rotator Cuff Injury Treatment Global Market to 2027 - Featuring 3S Ortho, Anika Therapeutics, Arthrex and BREG Among Others - ResearchAndMarkets.com

Retrieved on: 
Giovedì, Luglio 7, 2022
Health, General Health, Olympus Corporation, Decision-making, Acquisition, DJO, USD, Treatment, Ortho, Strategic management, Value, R, Business Growth Fund, COVID-19, Customer support, Growth, Smith & Nephew, LLC, Investment, Certification, CAGR, Stryker Corporation, Use, Rotator cuff, A, Agriculture, Retail, Medical device, Physical therapy, Injury, Medication

What are the inhibiting factors and impact of COVID-19 shaping the Global Rotator Cuff Injury Treatment Market during the forecast period?

Key Points: 
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Rotator Cuff Injury Treatment Market during the forecast period?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Rotator Cuff Injury Treatment Market?
  • What is the market share of the leading vendors in the Global Rotator Cuff Injury Treatment Market?
  • What modes and strategic moves are considered suitable for entering the Global Rotator Cuff Injury Treatment Market?

Enovis Completes Acquisition of Insight Medical Systems

Retrieved on: 
Mercoledì, Luglio 6, 2022
FDA, DJO, CEO, Integrated Medical Systems International, Elective surgery, DE, GLOBE, Growth, COO, ENOV, NYSE, Culture, Hip, Solution, Medical device

WILMINGTON, DE, July 06, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, announced that it has acquired Insight Medical Systems, a technology company dedicated to reimagining orthopedic surgical guidance.

Key Points: 
  • WILMINGTON, DE, July 06, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, announced that it has acquired Insight Medical Systems, a technology company dedicated to reimagining orthopedic surgical guidance.
  • Insights flagship solution, ARVIS, is the only FDA-cleared augmented reality solution precisely engineered for the specific needs of hip and knee replacement surgery.
  • We are excited to welcome Insights talented team to our Enovis family where we will work together to improve patient outcomes through the use of next generation augmented reality surgical guidance in orthopedic surgery, said Matt Trerotola, CEO of Enovis.
  • Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows.

Global Orthopedic Braces & Supports Market Report 2022: Industry Expected to Reach $5.1 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Giovedì, Giugno 23, 2022
Medical Devices, Health, CAGR, FDA, Obesity, Sport, Injury, PCL, Leg, Brace, Pain management, Osteoarthritis, Trauma, Elective surgery, ACL, Bone, Medial knee injuries, Marketing, Carpal tunnel syndrome, DJO, Surgeon, Acquisition, Partnership, Posterior cruciate ligament, Standard of care, Incidence, Tendinopathy, Patient, Rupture, DJO Global, Awareness, Diabetes, Essity, Anterior cruciate ligament, Risk, Medical device, Sports equipment, Dentistry

The Global Orthopedic Braces & Supports Market size is expected to reach $5.1 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.

Key Points: 
  • The Global Orthopedic Braces & Supports Market size is expected to reach $5.1 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.
  • Orthopedic braces and supports provide various advantages over traditional goods, including lower cost, improved efficacy, more patient comfort, and ease of use.
  • The rising number of leg and knee injuries has resulted in a jump in sales of knee braces and supports.
  • Knee braces and supports are used to treat ailments such as sprained medial knee ligaments, anterior cruciate ligament (ACL) rupture, and posterior cruciate ligament (PCL) rupture after surgery.

Enovis™, Formerly Branded DJO®, Introduces Arsenal Ankle Plating System™

Retrieved on: 
Mercoledì, Giugno 15, 2022
Health Technology, Health, Surgery, Medical Devices, Solution, Culture, Malleolus, Technology, Â, Elective surgery, ENOV, Colfax Corporation, Ownership, MD, DJO, General manager, Foot, History, Multimedia, NYSE, Printed circuit board, Ankle

* Enovis Corporation, an innovation-driven medical technology growth company, announced today the launch of the Arsenal Ankle Plating System.

Key Points: 
  • * Enovis Corporation, an innovation-driven medical technology growth company, announced today the launch of the Arsenal Ankle Plating System.
  • This system consists of 37 anatomically designed plates throughout nine plate families, offering a plating solution for any ankle fracture.
  • Enovis, formerly branded as DJO, introduces the new Arsenal Ankle Plating System.
  • (Photo: Business Wire)
    The Arsenal Ankle Plating System is the latest addition to Enovis suite of foot and ankle products and an expansion of Arsenal Foot Plating System, leveraging its history of proven results and pioneering technology.

Georgia Bio Names 2022 Golden Helix Award Winners

Retrieved on: 
Lunedì, Aprile 11, 2022
Health, Technology, Nanotechnology, Other Science, General Health, Research, Science, Bio, Industry, Therapy, University, National, Metro Atlanta Chamber of Commerce, Sale, Leadership, DJO, Partnership, Kennesaw State University, Danimer Scientific, Growth, Phoenix Award, Community, Association, Biotechnology, Research, Atlanta metropolitan area, CEO, MLB Industry Growth Fund, Center, Academy, NIH, Ecosystem, Intuition, MVM, Economic development, Year, History of the Georgia Institute of Technology, Film, Pharmaceutical industry, Innovation, Phoenix

Georgia Bio, the states life science trade association, will celebrate its annual Golden Helix Awards on Thursday, May 5th.

Key Points: 
  • Georgia Bio, the states life science trade association, will celebrate its annual Golden Helix Awards on Thursday, May 5th.
  • Georgia Bio is pleased to announce the winners of the 2022 Golden Helix Awards and be returning to an in-person celebration.
  • The Golden Helix Awards highlights those lasting contributions made by many in the life sciences sector in Georgia.
  • Now in its 24th year, the Golden Helix Award winners showcase the best in innovation and leadership in Georgias community.

Companion Animal Health Announces Strategic Investment in Early Cancer Detection Solution

Retrieved on: 
Martedì, Marzo 22, 2022
Veterinary, Technology, Medical Devices, Practice Management, Biotechnology, Alternative Medicine, Hardware, Health, Oncology, Heart, Classification, Sale, Rehabilitation, DJO, Diagnosis, Death, HDI, Survival rate, Veterinarian, Cat, Cancer, PETS, Approximation error, Companion, Pain management, Pain, Radiology, HT, Oncology, Goal, Dog, Heat, Solution, Education, AI, Patient, Partnership, Medical imaging, COMPANION ANIMAL HEALTH, HT BIOIMAGING

HDI enables early detection of cancer and classification of suspicious masses.

Key Points: 
  • HDI enables early detection of cancer and classification of suspicious masses.
  • Craig Tockman, President of Companion Animal Health, stated, "Cancer is the cause of death in 47% of dogs and 32% of cats, over the age of 10 years old.
  • Companion Animal Health delivers the most advanced technologies in pain management, photobiomodulation, rehabilitation, regenerative therapies, and diagnostics to veterinarians.
  • HT BioImaging is an Israeli-based company aiming to save the lives of both people and pets by early cancer detection.

Colfax Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation

Retrieved on: 
Lunedì, Marzo 14, 2022
U.S. Securities and Exchange Commission, SEC, Separation, Loss, Technology, GLOBE, Annual report, Board of directors, Book, Private Securities Litigation Reform Act, Wilmington, DE 2001, Nature, COVID-19, Forward-looking statement, Reverse stock split, Security (finance), FICC, DTC, DJO, Information, Board, ESAB, Company, Prevalence, CFX, Depository Trust & Clearing Corporation, NYSE, Bangladesh Securities and Exchange Commission, Date, New, Ownership, Vaccine Information Statement

As a result of the distribution, Colfax shareholders will receive one share of ESAB common stock for every three shares of Colfax common stock they hold on the Record Date (pre-Reverse Stock Split ratio).

Key Points: 
  • As a result of the distribution, Colfax shareholders will receive one share of ESAB common stock for every three shares of Colfax common stock they hold on the Record Date (pre-Reverse Stock Split ratio).
  • No action is required by Colfax shareholders to receive the distributed shares of ESAB common stock.
  • Colfax shareholders who hold Colfax common stock on the Record Date will either receive a book-entry account statement reflecting their ownership of ESAB common stock, or their brokerage account will be credited with ESAB shares.
  • Regular-way trading of ESAB common stock is expected to begin on the NYSE on April 5, 2022, under the symbol ESAB.

Therabody® Files Six Lawsuits to Protect its Intellectual Property and Curb Unauthorized E-Commerce Sales

Retrieved on: 
Mercoledì, Marzo 9, 2022
University, Intellectual property, Founder, Research, TJX Companies, Advertising, Juan de Homedes, HomeGoods, Patent, BOC, Health, MWA, Face, Multimedia, NASM, DNA, USDA, Marshalls, DJO, CompEx, Science, Sale, Reset, PACE, Powerdot, Solution, The 5th Wave (series), Organization, TJ Maxx, Amazon, Ridesharing company, Online shopping, 3D printing

"We partner with world-class retailers to educate their sales associates and consumers on the benefits of our proprietary products.

Key Points: 
  • "We partner with world-class retailers to educate their sales associates and consumers on the benefits of our proprietary products.
  • Since 2020, Therabody has successfully removed more than 1,000 unauthorized resellers from the global e-commerce platform that offered products that were ineligible for Therabody's limited warranty.
  • Unauthorized retailer sales are detrimental to consumers who are seeking to benefit from Therabody's world-class products and customer experience.
  • Therabody expends considerable resources to research, develop, and protect its intellectual property.

Colfax Announces Conditional Redemption of its 3.250% Senior Notes due 2025 and its 6.375% Senior Notes due 2026

Retrieved on: 
Lunedì, Marzo 7, 2022
Private Securities Litigation Reform Act, Condition, CUSIP, Attention, Name, Wilmington Trust, Prevalence, Forward-looking statement, Winchester House, U.S. Securities and Exchange Commission, Annual report, Deutsche Bank, Separation, Debt-to-GDP ratio, National Association, Revenue stream, DJO, NYSE, Suite, SEC, Company, Sale, COVID-19, Time, ESAB, Internal Revenue Service, CFX, DE, Nature, Intention, Technology, Colfax Corporation, Redemption, GLOBE, Bank, Note

On and after the Redemption Date, interest will cease to accrue on each series of Notes.

Key Points: 
  • On and after the Redemption Date, interest will cease to accrue on each series of Notes.
  • All redeemed Notes must be surrendered to the applicable paying agent to collect the applicable Redemption Price.
  • The Company uses its Colfax Business System, a comprehensive set of tools and processes, to create superior value for customers, stockholders and associates.
  • Colfax disclaims any duty to update the information herein.